NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market on Wednesday a 31 percent jump in second quarter revenues, setting a record for quarterly revenues based on higher test volume.

For the three-month period ended June 30, CombiMatrix's revenues rose to $2.5 million from $1.9 million in the prior-year period, beating analysts' average estimate of $2.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.